Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: Genet Epidemiol. 2011 Jan 31;35(3):159–173. doi: 10.1002/gepi.20564

Table 4. GENEVA Phenotype Working Groups.

Working Group Key variable(s) defined No. of contributing studies so far Approx. N Comment
Alcohol use Drinks per week, reported maximum, as a continuous measure 7 18,000 First studies used for replication; Meta-analysis to be considered when data on later studies are available
Anthropometric measures Height (m), continuous 7 42,000
Weight (kg) at study entry 6 36,000
Body Mass Index (BMI) 3 36,000
Weight (kg) at late adolescence or early adulthood 3 25,000 To be analyzed as part of a broader consortium with other, non-GENEVA studies
Adult weight gain 3 25,000 To be analyzed as part of a broader consortium with other, non-GENEVA studies
Waist circumference (cm) at study entry (also waist adjusted for BMI and height) 3 24,000
Hip circumference (cm) at study entry 2 23,000
Caffeine use Caffeine intake per day (mg/day) 3 25,000 Meta-analysis, including findings from subjects not part of GENEVA
Diabetes On hold
Hypertension Only two studies have actual blood pressure measures; discussing collaboration with another consortium
Oral health Various dental caries and periodontal disease variables (under development) 3 TBD
Physical activity and exercise Metabolic equivalent moderate/vigorous leisure activity min/day (continuous); Engagement in moderate/vigorous leisure activity (dichotomized) 6 TBD Planned meta-analysis, In-silico/de novo replication
Protective effects Under development 10 TBD
Psychiatric history Too much variance in the instruments to develop a meaningful harmonized variable across studies
Reproductive history Age at menarche 8 18,000 Four studies collaborated with another consortium for analysis
Age at menopause 8,500
Spontaneous loss TBD TBD
Sleep New working group, under development
Tobacco use G*E interactions 4 15,000 Under development

TBD = To be determined